Drug-resistant tuberculosis is a major challenge for the World Health Organisation (WHO). The emergence of multi-drug resistant tuberculosis is becoming increasingly apparent in Lomami hospitals. However, until now the forms reported have been pulmonary. We report here a case of multidrug-resistant extra-pulmonary tuberculosis (EPTB), the lymph node form. The case was diagnosed at the Kabinda General Referral Hospital (GRH). This case is reported to draw the attention of clinicians to the diagnosis of resistance in extrapulmonary forms and to demonstrate the importance of monitoring patient histories for the early diagnosis of drug-resistant tuberculosis.
Cite this paper
Kabeya, T. K. , Nsomue, D. M. , Lwayo, C. K. , Mpata, S. M. W. , Muembo, J. M. and Mutondo, R. M. (2025). Multi-Resistant Lymph Node Tuberculosis: A Case Reported in the Lomami Province in the Democratic Republic of the Congo. Open Access Library Journal, 12, e2852. doi: http://dx.doi.org/10.4236/oalib.1112852.
Slim-Saidi, L., Me-hiri-Zeghal, E., Ghariani, A. and Tritar, F. (2015) Nouvelles méthodes de diagnostic de la tuberculose. Revue de Pneumolo-gie Clinique, 71, 110-121.
https://www.em-consulte.com/article/966366/nouvelles-methodes-de-di
agnostic-de-la-tuberculose https://doi.org/10.1016/j.pneumo.2015.02.002
Amadou, M.L.H., Abdoulaye, O., Amadou, O., Biraïma, A., Kadri, S., Kabiru, A.A., et al. (2019) Profil épidémiologique, clinique et évolutif des patients tuberculeux au Centre Hospitalier Ré-gional (CHR) de Maradi, République du Niger. Pan African Medical Journal, 33, Article 120. https://doi.org/10.11604/pamj.2019.33.120.17715
Hochedez, P., Zeller, V., Truffot, C., Ansart, S., Caumes, é., Tubiana, R., et al. (2003) Caractéristiques épidémiologiques, cliniques, biologiques et thérapeutiques de la tuberculose ganglionnaire observée chez des patients infectés ou non par le VIH. Pathologie Biologie, 51, 496-502. https://doi.org/10.1016/s0369-8114(03)00145-7
Chahboune, M., Barkaoui, M., Iderdar, Y., Alwachami, N., Mourajid, Y., Ifleh, M., et al. (2022) Profil épidémiologique, aspects diagnostiques et évolutifs des patients tuberculeux au centre de diagnostic de la tuberculose et des maladies respiratoires de Settat, Maroc. Pan African Medical Journal, 42, Arti-cle 185. https://pmc.ncbi.nlm.nih.gov/articles/PMC9508374/ https://doi.org/10.11604/pamj.2022.42.185.35250
Fang, T., Xiang, Y., Li, W., Liu, B., Liu, H., Wu, Y., et al. (2024) Analysis on Epidemiological and Drug Resistance Characteristics of Lymph Node Tuberculosis from Hunan Province, China. Frontiers in Public Health, 12, Article 1432065. https://doi.org/10.3389/fpubh.2024.1432065
Misombo-Kalabela, A., Nguefack-Tsague, G., Mireille, G.C., Ze, E.A., Diangs, K., Panda, T., et al. (2016) Facteurs de risque de la tuberculose mul-ti-résistante dans la ville de Kinshasa en République Démocratique du Congo. Pan African Medical Journal, 23, Article 157. https://pmc.ncbi.nlm.nih.gov/articles/PMC4967428/ https://doi.org/10.11604/pamj.2016.23.157.6137
Gallant, V., Vachon, J. and Siu, W. (2017) La résistance aux antituberculeux au Canada: 2006 à 2016. Relevé des maladies transmissi-bles au Canada, 43, 269-275. https://doi.org/10.14745/ccdr.v43i11a05f
WHO (2020) Consolidated Guidelines on Tuberculosis: Module 3: Diagnosis-Rapid Diagnostics for Tuberculosis Detection. World Health Organization. (WHO Guide-lines Approved by the Guidelines Review Committee). http://www.ncbi.nlm.nih.gov/books/NBK570420/
Opota, O., Mazza-Stalder, J., Greub, G. and Jaton, K. (2019) The Rapid Molecular Test Xpert MTB/RIF Ultra: Towards Improved Tu-berculosis Diagnosis and Rifampicin Resistance Detection. Clinical Microbiology and Infection, 25, 1370-1376. https://doi.org/10.1016/j.cmi.2019.03.021
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C.M., et al. (2021) Xpert MTB/RIF Ultra and Xpert MTB/RIF Assays for Extrapulmonary Tuberculosis and Rifampicin Resistance in Adults. Cochrane Database of Systematic Reviews, No. 1, CD012768. https://pubmed.ncbi.nlm.nih.gov/33448348/ https://doi.org/10.1002/14651858.cd012768.pub3
Ketata, W., Rekik, W.K., Ayadi, H. and Kammoun, S. (2015) Les tuberculoses extrapulmonaires. Revue de Pneumologie Clinique, 71, 83-92. https://doi.org/10.1016/j.pneumo.2014.04.001
Haddaoui, H., Mrabet, F.Z., Aharmim, M. and Bourkadi, J. (2019) Tuberculose extrapulmonaire multi résistante: à propos de 7 cas. Pan African Medical Journal, 32, Article 196. https://doi.org/10.11604/pamj.2019.32.196.17995
Mukhida, S., Vyawahare, C.R., Mirza, S.B., Gandham, N.R., Khan, S., Kannuri, S., et al. (2022) Role of Genexpert MTB/RIF Assay for the Diagnosis of Cervical Lymph Node Tuberculosis and Rifampicin Resistance. Tzu Chi Medical Journal, 34, 418-422. https://doi.org/10.4103/tcmj.tcmj_86_22
Ghariani, A., Jaouadi, T., Smaoui, S., Mehiri, E., Marouane, C., Kammoun, S., et al. (2015) Diagnosis of Lymph Node Tuberculosis Using the GeneXpert MTB/RIF in Tunisia. International Journal of Mycobacteriology, 4, 270-275. https://doi.org/10.1016/j.ijmyco.2015.05.011
Lohiya, S., Tripathy, J.P., Sagili, K., Khanna, V., Kumar, R., Ojha, A. et al. (2020) Does Drug-Resistant Extrapulmonary Tuberculosis Hinder TB Elimination Plans? A Case from Delhi, India. Tropical Medicine and Infectious Disease, 5, Article 109. https://doi.org/10.3390/tropicalmed5030109
Utpat, K.V., Rajpurohit, R. and Desai, U. (2023) Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Exten-sively Drug-Resistant Tuberculosis (XDR-TB) among Extra Pulmonary (EP) Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai in Pre Bedaquiline (BDQ) Era. Lung India, 40, 19-23. https://doi.org/10.4103/lungindia.lungindia_182_22
WHO (2022) Operational Handbook on Tuberculosis. Module 4: Treatment—Drug-Resistant Tuberculosis Treatment. World Health Organization. https://www.who.int/publications/i/item/9789240065116
